e-learning
resources
2020
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The prognostic value of cardiopulmonary exercise testing in interstitial lung disease: a systematic review
Shaney L. Barratt, Richard Davis, Charles Sharp, John D. Pauling
Source:
ERJ Open Res, 6 (3) 00027-2020; 10.1183/23120541.00027-2020
Journal Issue:
July
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Shaney L. Barratt, Richard Davis, Charles Sharp, John D. Pauling. The prognostic value of cardiopulmonary exercise testing in interstitial lung disease: a systematic review. ERJ Open Res, 6 (3) 00027-2020; 10.1183/23120541.00027-2020
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The new challenge of CTD-ILD: from basic science to clinical setting
Time to breathe: How COVID-19 interacts with interstitial lung disease
Debate – Controversies in interstitial lung disease
Related content which might interest you:
The prognostic role of cardiopulmonary exercise testing in disease
Source: International Congress 2018 – PG16 Advanced cardiopulmonary exercise testing
Year: 2018
The prognostic role of cardiopulmonary exercise testing in disease
Source: International Congress 2019 – PG3 Advanced cardiopulmonary exercise testing
Year: 2019
The prognostic value of cardiopulmonary exercise testing in idiopathic pulmonary fibrosis
Source: Annual Congress 2011 - The prognostic value of cardiopulmonary exercise testing
Year: 2011
Exercise testing in the prognostic evaluation of patients with lung and heart diseases
Source: Eur Respir Monogr 2018; 80: 222-234
Year: 2018
Exercise testing in the prognostic evaluation of patients with lung and heart diseases
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 978-1-904097-49-5, page=195
Year: 2007
The prognostic significance of cardiopulmonary exercise in IPF
Source: Annual Congress 2011 - What is new in the approach to pulmonary fibrosis?
Year: 2011
Cardiopulmonary exercise test as prognostic tool in patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2007 - Considerations in the management of idiopathic pulmonary fibrosis and other interstitial lung diseases
Year: 2007
Value of cardiopulmonary exercise testing in interstitial lung diseases
Source: International Congress 2018 – New methods and concepts in exercise testing
Year: 2018
Exertional dyspnoea in interstitial lung diseases: the clinical utility of cardiopulmonary exercise testing
Source: Eur Respir Rev 2017; 26: 160099
Year: 2017
ERS statement on standardisation of cardiopulmonary exercise testing in chronic lung diseases
Source: Eur Respir Rev, 28 (154) 180101; 10.1183/16000617.0101-2018
Year: 2019
Cardiopulmonary exercise testing in interstitial lung diseases and the value of ventilatory efficiency
Source: Eur Respir Rev, 30 (162) 200355; 10.1183/16000617.0355-2020
Year: 2021
Chest wall volumes during constant compared to incremental cycle ergometer tests in chronic obstructive pulmonary disease (COPD) patients: A systematic review and meta-analysis
Source: International Congress 2015 – Respiratory muscles and airways function: from physiology to clinical implications
Year: 2015
Pre-operative pulmonary evaluation of lung cancer patients: a review of the literature
Source: Eur Respir J 2009; 33: 1206-1215
Year: 2009
Application of a predictive formula for hypoxic challenge testing in patients with interstitial lung disease
Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias
Year: 2018
The value of cardiopulmonary exercise testing in sarcoidosis
Source: International Congress 2015 – Clinical exercise physiology in health and disease
Year: 2015
Standardisation of cardiopulmonary exercise testing in chronic lung diseases: summary of key findings from the ERS task force
Source: Eur Respir J, 54 (6) 1901441; 10.1183/13993003.01441-2019
Year: 2019
Lung biopsy in interstitial lung disease: balancing the risk of surgery and diagnostic uncertainty
Source: Eur Respir J 2016; 48: 1274-1277
Year: 2016
Concurrent validity among three field tests and the cardiopulmonary exercise testing in patients with idiopathic pulmonary fibrosis.
Source: Virtual Congress 2020 – News on diagnosis and therapy of idiopathic pulmonary fibrosis
Year: 2020
Prognostic significance of autoantibodies for idiopathic pulmonary fibrosis: a systematic review and meta-analysis
Source: International Congress 2018 – Idiopathic interstital pneumonias other than idiopathic pulmonary fibrosis (IPF)
Year: 2018
Physical activity and mortality risk in people with interstitial lung disease: a systematic review and meta-analysis
Source: Virtual Congress 2021 – Physical activity, exercise training and (tele)rehabilitation in respiratory patients
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept